Health advocates call for lowering colorectal cancer screening age to 45
Health advocates are pushing for all provinces and territories to lower the screening age for colorectal cancer to 45 as a growing number of younger adults are getting the disease.
'Our objective is to ensure that young Canadians do not ignore the signs and symptoms just because of their age and that they are aware of their family medical history and risk level, as we call on our provincial and territorial health ministries to lower the screening age for colorectal cancer throughout the country to 45,' said Barry Stein, president and CEO of Colorectal Cancer Canada, in a statement on Tuesday.
Colorectal cancer screening is currently offered for those at 'average-risk' across Canada. Those at average risk are aged 50 to 74 who don't have symptoms and personal or family history of the following:
colorectal cancer
certain polyps
genetic conditions like Lynch syndrome
inflammatory bowel diseases such as Crohn's or colitis.
Colorectal Cancer Canada, a national non-profit group, said its advice follows the change made to U.S. guidelines in 2018 to include those aged 45 to 49 for screening based on 'evidence-based recommendations' from the American Cancer Society. Australia also reduced the starting age for bowel cancer screening to 45 from 50 in 2024.
What is the risk?
Although individuals aged 50 and older are mostly getting the cancer, Colorectal Cancer Canada said it's not 'an old person's disease' and the risk now is greater for younger adults compared to past generations.
Those born after 1980 are two to 2.5 times more likely to get colorectal cancer before they turn 50, according to Colorectal Cancer Canada. What's more, it said younger patients tend to be diagnosed with the disease at more advanced stages, which creates 'unique challenges' for prognosis and treatment.
Early onset colorectal cancer is rising among those below age 50, Colorectal Cancer Canada added. At the same time, Canada is seeing a declining number of cases and deaths for those 50 and older.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
6 hours ago
- CBC
Acupuncturist who sexually assaulted patients banned from registering with regulatory college for 30 years
A former registered acupuncturist who sexually assaulted two of his patients is not eligible to apply to reinstate his registration for 30 years. In a disciplinary notice posted to its site, the College of Complementary Health Professionals of B.C. (CCHPBC) says Mario Luis Ibarra will not be able to apply to reinstate his registration until July 1, 2055. It comes over four months after Ibarra pleaded guilty to two counts of sexual assault. In February, Ibarra, who practised in Surrey, B.C., was handed a jail sentence of two years less a day to be served in the community, and three years of probation after pleading guilty to two counts of sexual assault. He was also given a five-year ban from performing any complementary health service where he would be touching people. He will also be on a sex offender registry for 20 years. Ibarra was regulated by the College of Traditional Chinese Medicine Practitioners and Acupuncturists of British Columbia, which merged into the CCHPBC in June 2024. The regulator now also oversees professions like chiropractors and registered massage therapists. According to the notice, Ibarra's registration had already been terminated after he did not renew it on March 31, 2024. Should he apply for registration after the 30-year period, his eligibility would depend on successfully completing "courses on ethics and respecting boundaries" as required by the college's registrar or registration committee. He will also have to "meet all legislative and bylaw requirements relating to registration, including those relating to good character, risks to public safety, and the public interest." The notice also says Ibarra is required to pay $3,000 to the CCHPBC for its investigation. 'Disgusting and inexcusable' One of Ibarra's victims has said his actions have left her "struggling" to rebuild her life, and called his actions "disgusting and inexcusable." Both victims have also previously been critical of the regulator of B.C. acupuncturists for not warning the public about Ibarra, who continued to practise years after the assaults. The college began investigating Ibarra in 2022, but in a June 2023 email obtained by CBC News, the college said it decided to suspend its investigation until the criminal law proceeding was over. After Ibarra was sentenced in February, the college said its investigation would be "remitted to CCHPBC's Inquiry Committee for consideration." In its notice, the committee describes Ibarra's "admitted conduct" to be "extremely serious." It adds that the committee is satisfied that the order "appropriately reflects the seriousness of the admitted conduct and will protect patient safety as Mr. Ibarra is no longer authorized to [practise] as an acupuncturist in B.C."
CTV News
7 hours ago
- CTV News
Hogs for Hospice and ESHF move forward as separate organizations
Erie Shores Health Foundation (ESHF) and Hogs for Hospice are moving forward as separate, independent organizations, the foundation announced. As the 2025 Hogs for Hospice motorcycle rally approaches in August, ESHF issued a news release on Monday thanking the founding organizers and long-time supporters of Hogs for Hospice for their extraordinary contributions to local hospice care over the past 15 years. 'As we look ahead, given the event's growth and size, Erie Shores Health Foundation and Hogs for Hospice have mutually agreed to move forward as separate, independent organizations,' said the statement. 'This formal transition reflects best practices in charitable governance and reinforces each organization's autonomy.' Erie Shores Health Foundation will remain fully focused on its strategic priorities, including stewarding donations, supporting hospice and hospital care, and investing in long-term health outcomes for the region.
National Post
8 hours ago
- National Post
KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai
Article content New organizational structure will drive commercial growth, innovation, and overall business performance. Article content EL SEGUNDO, Calif. — KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Article content Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development, and manufacturing under a unified leadership structure for the region. Article content The formation of KARL STORZ North America reflects the company's commitment to enhancing operational efficiency, service, and value to its customers across a broader geographic footprint. Article content 'After 80 years, KARL STORZ's mission remains the same – to improve patient lives,' said Matai, President of KARL STORZ North America. 'The decision to unify our businesses across North America underscores our commitment to our customers and their evolving needs in patient care. This is an exciting opportunity to leverage exceptional talent from both countries, which will only strengthen our ability to bring solutions to market with greater speed and agility.' Article content Effective today, KARL STORZ North America encompasses six locations in the US and a Canadian and Veterinary hub in Mississauga, Ontario, a region recognized for its booming medical technology sector. Changes to the organizational structure will cause no anticipated disruption to services, product availability, or customer support. Article content About KARL STORZ Article content KARL STORZ is an innovative leader in endoscopic technology and surgical imaging solutions across virtually all surgical specialties. Its integrated OR solutions, including advancements in digital surgery, enhance collaboration to improve clinical efficiency and outcomes inside the hospital and across other sites of care. With subsidiaries around the world, KARL STORZ is a family-owned company based in Germany that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, visit Article content Article content Article content
